The importance of TNFAIP3 in reducing inflammation is underlined by the linking of TNFAIP3 genomic region polymorphisms with human autoimmune and inflammatory diseases, including RA [110], psoriasis [111], SLE [112], and type 1 diabetes [113]. This evidence concerns the gene TNFAIP3 and systemic lupus erythematosus.